Table 2 Characterization of the CF group.

From: Subclinical vascular, hemodynamic and arterial stiffness changes in adults with cystic fibrosis: cross-sectional observational study

Characteristic

CF (n = 36)

Spirometry

  FVC (L)

2.76 ± 0.97

  FVC% of predicted

66.33 ± 21.15

  FEV1 (L)

1.77 ± 0.80

  FEV1% of predicted

49.36 ± 20.85

  FEV1/FVC

0.63 ± 0.11

  PEF (L/min)

346.17 ± 110.94

Mutation

  Homozygous F508del

3 (8.34%)

  Heterozygous F508del

16 (44.44%)

  Others

17 (47.22%)

Usual medications

  Dornase alfa

36 (100%)

  Inhaled antibiotic

22 (61.11%)

  Pancreatic enzyme

25 (69.44%)

Airway colonization

  Pseudomonas aeruginosa

15 (41.66%)

  Staphylococcus aureus

10 (27.78%)

  Pseudomonas aeruginosa and Staphylococcus aureus

10 (27.78)

  Non-colonized

1 (2.78%)

Sweat test (mEq/L)

100.53 ± 18.82

  1. The data is presented in mean ± SD for the spirometry variables and in absolute and relative frequency for the sweat test and other parameters. FVC: Forced vital capacity; FEV1: Forced expiratory volume in the first second; PEF: Peak expiratory flow.
Back to article page